The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
De Facto Long-term Opioid Therapy for Noncancer Pain
Open accessAbstract
OBJECTIVES: This paper describes characteristics of opioid use episodes for noncancer pain and defines thresholds for de facto long-term opioid therapy. METHODS: CONSORT (CONsortium to Study Opioid Risks and Trends) includes adult members of 2 health plans serving over 1% of the US population. Opioid use episodes beginning in the years 1997 to 2005 were classified as acute, episodic, long-term/lower dose, or long-term/higher dose. RESULTS: On the basis of evaluation of the likelihood of opioid use continuing, long-term opioid therapy was defined by episodes lasting longer than 90 days with 10+ opioid prescriptions or 120+ days supply of opioids dispensed. Long-term/higher dose episodes (<1.5% of all opioid use episodes) were characterized by daily or near daily use, a mean duration of about 1000 days, and an average daily dose of about 55 mg. They accounted for more than half the total morphine equivalents dispensed from the years 1997 to 2006. Short-acting, non-Schedule II opioids (eg, hydrocodone with acetaminophen) were, by far, the most commonly prescribed medications for acute, episodic, and long-term episodes. Long-acting (sustained-release) opioids were the predominately prescribed medication in a minority of long-term episodes (6% to 12%). DISCUSSION: Long-term opioid therapy was characterized by the diversity in medications prescribed, dosage levels, and frequency of use. The proposed threshold for long-term opioid therapy provides a checkpoint for physicians to review whether an explicit decision to sustain opioid therapy has been reached, and to ensure that a documented treatment plan and provisions for monitoring medication use and patient outcomes are in place.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 959
Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects
Furlan, A. D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051528 · Cited by 873
Martell, B. A., O'Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R., & Fiellin, D. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00006 · Cited by 774
Zacny, J., Bigelow, G., Compton, P., Foley, K., Iguchi, M., & Sannerud, C. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00003-6 · Cited by 517
Opioid dependence and addiction during opioid treatment of chronic pain
Ballantyne, J. C., & LaForge, S. K. (2007) · Pain · doi:10.1016/j.pain.2007.03.028 · Cited by 447
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000
Caudill-Slosberg, M. A., Schwartz, L. M., & Woloshin, S. (2004) · Pain · doi:10.1016/j.pain.2004.03.006 · Cited by 374
Chou, R., Clark, E., & Helfand, M. (2003) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.03.003 · Cited by 229
Foundations of Opioid Risk Management
Katz, N., Adams, E., Benneyan, J., Birnbaum, H., Budman, S., Buzzeo, R. W., Carr, D., Cicero, T., Gourlay, D., Inciardi, J., et al. (2007) · The Clinical Journal of Pain · doi:10.1097/01.ajp.0000210953.86255.8f · Cited by 147
Potent opioids for chronic musculoskeletal pain: flying blind?
Korff, M. V., & Deyo, R. A. (2004) · Pain · doi:10.1016/j.pain.2004.02.019 · Cited by 107
Self-citationAcetaminophen, Aspirin, or Ibuprofen in Combination Analgesic Products
Barkin, R. L. (2001) · American Journal of Therapeutics · doi:10.1097/00045391-200111000-00008 · Cited by 92
Opioids for Chronic Nonterminal Pain
Ballantyne, J. C. (2006) · Southern Medical Journal · doi:10.1097/01.smj.0000223946.19256.17 · Cited by 66
Non-NSAID pharmacologic treatment options for the management of chronic pain
Schnitzer, T. J. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00073-4 · Cited by 62
Vieweg, W. V. R., Carlyle, W. F., & Fernandez, A. (2005) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v07n0301 · Cited by 51
Federal and state regulation of opioids.
De, J. (1990) · PubMed · Cited by 40
Opioids: After Thousands of Years, Still Getting to Know You
Katz, N. P. (2007) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31803cb905 · Cited by 28
Cited by
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., et al. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.10.008 · Cited by 2,192
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
Simon, L. S. (2012) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2012.678473 · Cited by 2,183
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,305
Opioid Prescriptions for Chronic Pain and Overdose: A Cohort Study
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta-Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,255
Self-citationVital signs: changes in opioid prescribing in the United States, 2006-2015.
Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6626a4 · Cited by 1,117
Metadata
- Authors
- Korff, M. V., Saunders, K., Thomas Ray, G., Boudreau, D., Campbell, C., Merrill, J., Sullivan, M. D., Rutter, C. M., Silverberg, M. J., Banta-Green, C., & Weisner, C.
- Venue
- The Clinical Journal of Pain
- Published
- 2008-07
- Volume
- 24
- Issue
- 6
- Pages
- 521-527
- ISSN
- 0749-8047 (ISSN-L)
- OpenAlex
- W1990355279
- Cited by
- 662
- References
- 16
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.